Factors contributing to the CAGR are high prevalence of the disease and growing nutritional disorders. Furthermore, key factors such as technological development, agreements and product launches are fueling the market growth of medical foods

the global medical foods market was valued at USD 17.27 billion in 2018 and is expected to reach USD 29.54 billion by 2026, at a CAGR 6.9% Medical foods are planned for specific dietary management of a disease or a condition for which distinctive nutritional requirements, based on recognized scientific principles are established by medical evaluation. It is mandatory to consume medical foods under the supervision of a physician. Medical foods are to be consumed or administered enterally. Specially formulated and intended for the dietary management of a disease that has distinctive nutritional needs that cannot be met by normal diet alone are known to be medical foods. Medical foods are not required to undergo premarket review or approval by FDA. Besides, they are relieved from the labeling requirements for health claims and nutrient content claims under the Nutrition Labeling and Education Act of 1990. Medical foods are customized for both pediatric and adult use and are available in a variety of forms, including powders, liquids, capsules, tablets, and bars. Moreover, they are specialized blends of macronutrients, vitamins, minerals, phytochemicals, and botanicals or preparations composed of a single nutrient.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1491

Some of the key players operating in the Medical Foods market include:

Protruding players operating in the market include Danone, Primus Pharmaceuticals, Inc., Nestlé, Abbott, Meiji Holdings and Co., Targeted Medical Pharma, Inc., Mead Johnson & Company, LLC., Accera, Inc., and Alfasigma.

Segments covered in the report:

On the basis of regional analysis, the market is segmented into key geographical regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. According to the analysis, North America is expected to dominate the market with the highest market share. Asia-Pacific is anticipated to show a significant growth rate owing to rising development and population demands.

Type (Revenue in USD Million; 2016–2026)

  • Pills and tablets
  • Powder
  • Others

Applications (Revenue in USD Million; 2016–2026)

  • Chronic kidney disease
  • Minimal hepatic encephalopathy
  • Chemotherapy-induced diarrhea
  • Pathogen-related infections
  • Diabetic neuropathy
  • ADHD
  • Depression
  • Alzheimer’s disease
  • Nutritional deficiency
  • Orphan diseases
    • Phenylketonuria
    • Eosinophilic esophagitis
    • FPIES
    • Others
  • Other

Route of Administration (Revenue in USD Million; 2016–2026)

  • Oral
  • Enteral

Sales Channel (Revenue in USD Million; 2016–2026)

  • Online Sales
  • Institutional Sales
  • Retail Sales

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1491

Beneficial Aspects of the Report:

  • Global and region forecast of the Medical Foods market from 2020-2027
  • In-depth analysis of market dynamics, industry outlook, market size based on types and applications
  • Details of value chain analysis, supply and demand ratio, production and consumption patterns
  • SWOT Analysis, Porter’s Five Forces Analysis, Feasibility Analysis, and Investment Return Analysis to provide a better understanding of the market and competitive players
  • Detailed insights on competitive landscape and emerging market trends

Research Methodology:

The market report is formulated on the basis of data obtained through extensive primary and secondary research. The data is further validated and verified by industry experts, research analysts, and professionals. The report considers regional demand and supply ratio, investments, market dynamics, capacity, end-use industry trends, and consumer behavior to generate a forecast report. The data is collected from verified sources such as government policies, regulatory published materials, journals, trade magazines, and verified data sources. The report uses advanced analytical tools such as SWOT Analysis, Porter’s Five Forces Analysis, Feasibility Analysis, and Investment Return Analysis to provide an accurate insight into the market scenario and competitive landscape. This report provides beneficial information to companies and new players to make lucrative business decisions. The market estimates and forecast data have been thoroughly verified through exhaustive primary research.

To read more  about the report – https://www.reportsanddata.com/report-detail/medical-foods-market

Thank you for reading our report. Reports and Data provides customization of the report as per the needs of the clients. For further inquiry on customization, please connect with us and our team will ensure the report is tailored to fit your requirements.

Browse More Details:

Neuroscience Antibodies and Assays Market: https://www.biospace.com/article/neuroscience-antibodies-and-assays-market-size-to-reach-usd-7-06-billion-in-2028-says-reports-and-data

Cochlear Implant Market: https://www.biospace.com/article/cochlear-implant-ci-market-size-to-reach-usd-4-21-billion-in-2028-noted-reports-and-data

Creatinine Measurement Market: https://www.biospace.com/article/creatinine-measurement-market-size-to-value-at-usd-841-01-million-in-2028

Lung In Vitro Model Market: https://www.biospace.com/article/lung-in-vitro-market-size-to-reach-usd-976-9-million-in-2028-says-reports-and-data

C-Reactive Protein Testing Market: https://www.biospace.com/article/c-reactive-protein-testing-market-size-to-reach-usd-1-93-billion-in-2028-says-reports-and-data

 

 

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here